Ads
related to: atopic dermatitis- Before & After Photos
See the Before and After of What
A Treatment Option Can Do For You.
- What Is Eczema?
Find Important Facts & Information
To Understand Atopic Dermatitis.
- Eczema Causes
Learn More About The Causes
Of Eczema (Atopic Dermatitis).
- Atopic Dermatitis
Learn About Causes, Symptoms,
& An Oral Treatment Option.
- Take Our Symptoms Quiz
Take Our Quiz To Learn
About Your Symptoms.
- Sign Up for Info
Get Updates, Answers, and Resources
For Treatment Support
- Before & After Photos
Search results
J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate
Zacks via Yahoo Finance· 2 days agoJ&J (JNJ) is set to acquire Yellow Jersey Therapeutics, which holds NM26 rights, from Numab's...
Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 1 day agoThe year-over-year rise in sales was driven by patient demand and expansion in payer coverage as...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 5 hours agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
Sofia Vergara Is Pro-Sunscreen and Pro-Plastic Surgery
Allure via Yahoo News· 3 days agoAfter spending the day in educational sessions on topics ranging from ichthyosis to atopic ...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks· 14 hours agoFree Report) and Regeneron (REGN Quick QuoteREGN - Free Report) announced that the FDA extended the review period for a regulatory filing seeking label expansion for their blockbuster drug Dupixent ...
J&J acquires experimental skin disorder drug for $1.25 billion
Reuters· 3 days ago, opens new tab on Tuesday agreed to acquire the rights to an experimental skin disorder treatment...
Dupilumab: Future Treatment for Pediatric Alopecia Areata?
Medscape· 3 days agoChildren with concomitant atopic dermatitis (AD) and alopecia areata (AA) who were treated with...
J&J acquires experimental skin disorder drug for $1.25 billion
Reuters via Yahoo News· 3 days agoJ&J will acquire a unit of Numab, backed by the parent of Danish drugmaker Novo Nordisk, to gain...
Q4 2024 Roivant Sciences Ltd Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 12 hours agoWe continue to make progress at Dermavant, with VTAMA's sNDA now in for atopic dermatitis with a PDUFA date at the end of this year. And with continued ...
Earnings call: Roivant reveals Q4 2023 results and strategic growth plans By Investing.com
Investing.com· 23 hours agoRoivant Sciences (NASDAQ:ROIV), in its Fourth Quarter 2023 Earnings Conference Call, outlined its...
Ad
related to: atopic dermatitis
